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Hepatocellular carcinoma is one of the most aggressive human tumours. It is the ﬁfth most common cancer and third highest in
terms of mortality in the world (Pang and Poon, 2012; Shen and Cao, 2012). Standard medical treatments of hepatocellular cancer
include surgical resection, ethanol or radiofrequency ablation (Zhang et al., 2009). Radiofrequency ablation and ethanol ablation
are recognized as effective treatment for small encapsulated hepatocellular carcinomas with a diameter less than 3 cm. However,
most patients have larger tumours at the moment of detection, and resection of tumours located near great vessels or the bile
ducts is not performed.
It is rare for large tumours to respond to treatmentwith radiofrequency or chemical ablation, and it is almost impossible to secure
whole ablation using thesemethods. During the late stage of disease, embolization (transcatheter arterial chemoembolization, TACE)
can be applied,which is performedby the introduction of a chemotherapeutical drug into thehepatic artery (Tono et al., 2013). During
this procedure, drugs, which block growth of blood vessels (Sorafenib, Avastin) (Lee et al., 2014), or drugs which affect the cell cycle
and stimulate apoptosis of cancer cells (Doxorubicin, Cisplatin, 5-FU) (Kudo, 2012) are used. Although useful, chemotherapeutic drugs
have a disadvantage: the development of side effects. Of note are the negative consequences of using cell cycle blocking drugs,.V. on behalf of Far Eastern Federal University. This is an open access article under the CC BY-NC-ND license
102 N.P. Bgatova et al. / Achievements in the Life Sciences 8 (2014) 101–111particularly Doxorubicin, which causes numerous effects. These effects include cytotoxicity of the drug and its metabolites on liver
cells (predominantly on hepatocytes), evident haemodynamic abnormalities in greater circulation (Nepomnyashchikh et al., 2006)
and considerable toxic inﬂuence on other organ systems, speciﬁcally cardiovascular (Nepomnyashchikh et al., 2005).
The mechanistic effects of other drugs on tumour growth, including lithium drug, are also known. For example, lithium carbonate
is used to enhance traditional thyroid cancer therapy (Tiuryaeva et al., 2010; Wolff et al., 2010) and as a drug contributing to resto-
ration of marrow and blood constituents after chemotherapy. The following effects were noted: normalization of neutrophil content
in the blood after radiotherapy and chemotherapy (Hager et al., 2001), restoration of platelet content in the blood (Hager et al., 2002),
increased CD34+ cells in the blood during leukaemia (Canales et al., 1999) and enhanced cytokine production during breast cancer
(Merendino et al., 1994). There are data on the use of lithium carbonate as a neuroprotective agent for cancer patients; its purpose is to
increase quality of lifewhile saving cognition, improving their emotional state (Yang et al., 2007; Khasrawet al., 2012) and preventing
peripheral neuropathy development during aggressive courses of chemotherapy (Mo et al., 2012). Recent research has been conduct-
ed showing the efﬁciency of lithium as an agent for tumour growth suppression (Wang et al., 2008; Zhu et al., 2011). Lithium com-
pounds are regarded as potential agents of target therapy, capable of slowing tumour growth. At the same time, with the
development of nanotechnology, new, more innovative features of nanoscale structures are being revealed (Golokhvastov et al.,
2013). In previous research we revealed biological effects of lithium carbonate nano-scaled particles during their introduction to in-
tact animals (Bgatova et al., 2012). The purpose of this work was to study the inﬂuence of lithium carbonate nano-scaled particles on
structural and metabolic changes in CBA mice with hepatocellular carcinoma development.
Methods
Experiments were performed on CBA line male mice from the Institute of Cytology and Genetics SB RAS. Mice weighted 18–20 g
and were three months of age. Work with animals was performed according to the principles of humanity stated in directions of EC
(86/609/ЕЕС) and Declaration of Helsinki.
Tomodel the tumour process, we used hepatocellular carcinoma-29 (H-29) cells. This tumour can cause considerable decrease in
its carriers' bodyweight and evident symptoms of cachexia. Hepatocellular carcinoma-29was generated and veriﬁed by employees of
the Institute of Cytology and Genetics SB RAS and kindly granted for our research (Kaledin et al., 2009). H-29 cells were transferred to
the abdominal cavity of CBA linemice. After 10 days, we made intake of ascitic ﬂuid, slurried in 10-fold volume of saline and injected
in 0.1ml into intact animals' right thighmuscle. To study the inﬂuence of inorganic nano-scaled particles on tumour developmentwe
injected lithium carbonate nano-scaled particles in doses of 0.037mg per animal once or ﬁve times after induction of tumour growth.
We made an intake of material on 3, 7, 13 and 30 days after injection of tumour cells. Animals were taken out of experiment under
etheric narcosis by cranio-cervical dislocation. We took ﬁve animals for each stage of the research.
We took biological samples for light optic research from thighmuscular tissue, regional inguinal lymph node, kidney, liver, hepatic
lymph node, hepatocellular carcinoma-29 cells and from ascitic ﬂuid. These samples were ﬁxed in 10% solution of neutral formalin,
dehydrated with a number of alcohols with increasing concentration and placed into parafﬁn. Sections 5–6 μm thick were coloured
with Mayer's haematoxylin and eosin and placed into Canada balsam.
To study biological samples using the electronmicroscope's translucentmode, we ﬁxed them in 1% solution ofОsO4 on phosphate
buffer (pH = 7.4), dehydrated them using increasing concentrations of ethanol and placed into Apon. From derived blocks, we
prepared semi-ﬁne sections 1-μm thick, coloured them with toluidine blue and studied them under a light microscope, choosing
the tissue areas to further study using an electron microscope. From selected material, we obtained ultrathin sections 35–45 nm
thick using ultratome LKB-NOVA. We contrasted these sections with a saturated water solution of uranyl acetate and lead citrate.
We then studied the sections using an electron microscope JEM 1010.
Derived microphotos were morphometrized using Image J software. Digital data were processed using generally accepted statis-
tical methods. We calculated arithmetic mean (M), mean sample error (m) and signiﬁcance level of distance between mean values
(p), based on Student's test for conﬁdence level 95% (p b 0.05).
Muscular tissue damage degreewas estimated by intensity of lipid peroxidation processes. For determination of lipid peroxidation
activity, we homogenized samples of right thigh muscular tissue in cold conditions in 2 ml of 0.85% NaCl water solution, which
contained 0.1% EDTA, using a Potter homogenizer. Then, we centrifuged samples for 15min at 4000 rpm.We determined the activity
of lipid peroxidation in homogenates by determining the concentration of reaction products of thiobarbituric acid (TBA)
(Volchegorsky et al., 2000). The concentration of TBA-active products was estimated at the wavelength of 532 nm and expressed in
micromole/kg, considering molar extinction coefﬁcient equal 1.56 × 105 mol−1 cm−1. For efﬁciency estimation of tissue protection
from products that can initiate and intensify lipid peroxidation, we studied the state of antioxidant system's enzymatic link by
evaluating the level of catalase and superoxide dismutase (SOD) activity.
The function of catalase is to prevent the accumulation of hydrogen peroxide. Hydrogen peroxide is generated during dismutation
of superoxide anion and aerobic oxidation of ﬂavoproteins. SOD catalyses dismutation of superoxide radicals, thereby preventing
pathogenic effects of reactive oxygen species. Enzymatic reactions can generate low levels of superoxide anion and hydrogen peroxide
Н2О2, which usually are not able to initiate directly lipid peroxidation processes. However, as a result of a numerous consecutive
reactions with enzymes and metal ions of variable valence, highly reactive compounds possessing energy can be formed, which
can result in C\H-bond breakage and primary lipid radicals' formation.
Catalase activity was estimated by the ability of hydrogen peroxide to make a stable dyed complex with molybdenum salts. Mea-
surementswere conducted at awavelength of 410 nmand expressed inU/100mgof tissue, considering hydrogen peroxidesmillimo-
lar extinction coefﬁcient equal 22.2 × 103 mmol−1 cm−1. Next, we determined SOD activity in tissue homogenates by the ability of
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Fig. 1. Volume density (Vv) of blood microvessels in tumours. T — tumour; T + Li — 20 days after ﬁve-fold injection of lithium carbonate nano-scaled particles on a
periphery of tumour growth. * — P b 0.05 compared with tumour of control group.
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interaction between the deoxidised form of nicotinamide adenine dinucleotide (NAD) and phenazine methosulfate. Quantitative
characteristics of the progressing reaction weremeasured at a wavelength of 540 nm.We considered 50% inhibition of nitro blue tet-
razolium deoxidation reaction as the activity unit. Enzyme activity was expressed in conventional units (U) per 100mg of tissue. Pro-
tein concentration was measured according to the generally accepted Lowry et al. (1951) method.
Determination of arginase activity was based on carbamide rate of production (Corraliza et al., 1994). We lysed macrophages by
freeze-thawing them twice, and then we added 50 μl of 50 mmol Tris–НCl (рН 7.4) and 10 μl of 50 mmol of manganese chloride
solution to 50 μl of lysate. Arginasewas activated by heating it to 57 °C for 10min in humid condition, whichwas obtained by prelim-
inarily wetting of plate lid with Hanks solution. Next, we added 100 μl of 0.5 mol L-arginine solution to each sample and incubated
them for 30 min at 37 °C. The reaction was stopped by placing the plate on ice in a refrigerating chamber. Carbamide concentration
was estimated by a double enzymatic reaction method. Reaction product quantity was measured via a “SmartSpec Plus” spectropho-
tometer (Bio-Rad, USA) at a wavelength of 340 nm.
Estimation of haemoglobin in tissue homogenates was conducted according to the haemiglobincyanide method. This method
based on the haemoglobin feature, in which it interacts with ferricyanic potassium and haemoglobin oxidizes into methaemoglobin.
Methaemoglobin combinedwith acetone cyanohydrin generates dyed haemiglobincyanide,whose colouringpower is proportional to
the amount of haemoglobin. Measurement of haemoglobin concentration was performed at a wavelength of 540 nm.
We judged hypoxia development in tumour-bearingmuscular tissue by the level of lactate concentration,whichwasmeasured by
the enzymaticmethod. Thismethod is based on oxidation of lactic acid into pyruvic by lactate dehydrogenase enzyme simultaneously
with deoxidation of nicotinamide adenine nucleotide (NAD+) into NADH. Lactate concentration was determined at a wavelength of
340 nmandwas expressed inmicromole/g of tissue using amolar extinction coefﬁcient equal to 6.22 × 103mol−1 cm−1. Allmeasure-
ments were performed using the “SmartSpec Plus” spectrophotometer (Bio-Rad, USA).
Peritoneal macrophages for study were obtained by peritoneal lavage. We injected 7 ml of 199 mediumwith 10 units/ml of hep-
arin intraperitoneal. After 2min,we retrieved themacrophageswith a syringe culturalmedium containing cells of peritoneal exudate.
Cell suspensions were washed using the 199 medium with 10 units/ml of heparin centrifuging for 10 min under 1500 rpm. Cell sed-
iment separated via centrifugation was resuspended in DMEM/F12 cultural medium containing 10% of foetal calf serum, 15 mmolFig. 2. Deformation of tumour cells' nuclei 20 days after ﬁve-fold injection of lithium carbonate nano-scaled particles. Toluidine blue stain. Magniﬁcation: 10 × 90.
Fig. 3. Structure of a mouse regional inguinal lymph node after injection of lithium carbonate nano-scaled particles on the periphery of tumour growth.
Haematoxylin and eosin stain. Magniﬁcation: 10 × 40. A — Increased content of macrophages in secondary lymphoid follicle after single dose of lithium
nano-scaled particles. B — Increased sizes of cerebral sinuses after single dose of lithium carbonate nano-scaled particles. C — Tumour cells in inguinal
lymph node sinuses at day 30 of the experiment. D — Replacement of lymphoid parenchyma with tumour cells after 30 days of experiment.
104 N.P. Bgatova et al. / Achievements in the Life Sciences 8 (2014) 101–111HEPES, 0.3% L-glutamine, and 50 μg/ml gentamicin. To study the peritoneal macrophages, we inserted them into the wells of 96-well
plates at a density of 2.0 × 105 cells in a volume of 200 μl, which was then incubated for 2 h (at 37 °C, 5% СО2). Nonadherent fraction
was removed, irrigated twicewith a freshmedium and then allowed incubation for 18 additional hours. NOproductionwas estimated
by nitrite content (micromole) in the cell culture supernatants.We added 100 μl of Griss reagent to 100 μl of supernatant,mixed it and
allowed it to incubate for 15 min before measuring the amount of reaction product using the “SmartSpec Plus” spectrophotometer
(Bio-Rad, USA) at a wavelength of 540 nm.
The study of metabolic characteristics was performed in homogenates of the liver and muscular tissues, taken from the area of
tumour cell inoculation. Samples of right thigh muscular tissue and liver were homogenized using a Potter homogenizer in cold
conditions with 2 ml of 0.85% NaCl water solution, containing 0.1% EDTA. Next, we centrifuged the samples for 15 min at
4000 rpm. Lactic acid concentration was determined using the set of reagents, “Boehringer Mannheim” (Germany). We determined
level of triglycerides using the set of reagents, “Vector-Best” (Russia). The level of glycogen was estimated according to the
Volchegorsky et al. (2000) method. Activity of arginase and NO was estimated according to the methods described above. ToFig. 4. Tumour cells in inguinal lymph node structure 25 days after termination of lithium carbonate particles' injection into the region of tumour growth. Increased
content of microvessels, macrophages and neutrophils. Toluidine blue stain. Magniﬁcation: 10 × 100.
Fig. 5.Metastases of tumour cells in the liver and increased content ofmacrophages, 30 days after transplantation of hepatocellular carcinoma (H-29) cells into the thigh
region of experimental animals, against the background of lithium carbonate nano-scaled particle introduction. Toluidine blue stain. Magniﬁcation: 10 × 40.
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10min at 3000 rpm.We processed the obtained results using generally acceptedmethods of variational statistics: dispersion analysis
ANOVA and further analysis of batch-to-batch variation using Newman–Keuls test or Mann–Whitney U-test.Results
After single dosing of lithium carbonate nano-scaled particles,we noted tumour cell necrosis on a periphery of tumour growth and
increased content of macrophages in a tumour. Phagosomes with lithium carbonate particles were revealed in the macrophages'
cytoplasm. At the same time, no tumour cells necrosis was noted in tumour development without lithium inﬂuence, mitosis ﬁgures
were observed, and quantitative density of macrophages was 40% lower. In this group of animals, 13 days after the start of the exper-
iment, the areas of tumour growth cells were located close and were large in size, and nomacrophages were detected in their micro-
environment. Determination of bloodmicrovessel volume density in tumours revealed its growth an average of 4.5 times on the third
and seventh days of tumour development. Bloodmicrovessel volume density decreased by 40% on the 13th day of the study, exceed-
ing reference level 2.5 times, and increased again by the 30th day of the experiment (Fig. 1).
Within 30 days post-implantation of hepatocellular carcinoma-29 cells into thighs of experimental animals, the tumour cells
formed the likeness of hepatic plates, surrounded by “sinusoids”. Tumour cells were large-sized, had a light nuclei with a large nucle-
olus. By the 30th day of study, animals injectedwith lithium carbonate nano-scaled particles on a periphery of tumour growth, did not
appear to have plate structure of tumour, had lesser observed vasculature development, the presence of macrophages was retained,
and tumour cells with deformed vacuolated nuclei were noted (Fig. 2).
In the single dose lithiumnano-scaled particle group, we noted a regional inguinal lymphnode structurewith increased secondary
lymphoid follicle number, and increasedmacrophage numeral density (Fig. 3A). Lymphatic sinuses, especially cerebral, were enlarged
(Fig. 3B). During 3–15 days of the experiment, we did not ﬁndmetastases in a regional inguinal lymph node. Multiple-dose introduc-
tion of lithium nano-scaled particles favoured the retention of signs of drainage and detoxiﬁcation and an increase in organ function,
including a considerable dilation of marginal and cerebral sinuses and the growth of macrophages' content in them.
Thirty days after tumour cell implantation, we found metastases in sinuses and lymphoid parenchyma of regional lymph node
(Fig. 3C, D). Replacement of lymph node structure by tumour cells indicated the development of the lymph's suppressionmechanism.Table 1
The content of TBA-active products in thigh muscular tissue under correction of tumour process by lithium carbonate nano-
scaled particles (М ± m).
Terms of investigation Animal groups
Tumour Tumour + Li2CO3
Intact 10.86 ± 0.87 (4)
3 days 4.47 ± 1.37⁎ (4) 5.06 ± 1.46⁎ (4)
7 days 23.2 ± 7.75 (3) 9.64 ± 1.39+ (5)
13 days 15.18 ± 1.37⁎(4) 10.66 ± 2.12 (4)
33 days 1.79 (1) 3.21 (1)
Comment: the number of animals is included in parentheses.
⁎ P b 0.05 compared with control.
+ P b 0.05 compared with the group of animals with spontaneous tumour development.
Table 2
The content of catalase and superoxide dismutase in thigh muscular tissue under correction of tumour process by lithium carbonate nano-scaled particles (М ± m).
Terms of investigation Catalase (U/100 mg) Superoxide dismutase (U/100 mg)
Tumour Tumour + Li2CO3 Tumour Tumour + Li2CO3
Intact 24.9 ± 7.7 (4) 162.9 ± 6.6 (4)
3 days 23.7 ± 7.3 (4) 36.6 ± 12.6 (4) 152.1 ± 10.4 (4) 138.4 ± 66.1 (4)
7 days 12.1 ± 6.5 (3) 23.7 ± 3.8 (5) 87.9 ± 19.5⁎(5) 74.9 ± 23.4⁎⁎ (3)
13 days 91.4 ± 12.3⁎(4) 95.4 ± 12.8⁎ (4) 107.2 ± 38.2 (4) 111.7 ± 35.1 (4)
33 days 31.0 (1) 36.4 (1) 93.1 (1) 135.4 (1)
Comment: the number of animals is stated in parentheses.
⁎ P b 0.05.
⁎⁎ P b 0.01 compared with control.
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increase of macrophages and neutrophil numbers during tumour development and the conditions of lymph node metastasis. Addi-
tionally, blood microvessel volume density was increasing signiﬁcantly in the area of tumour growth (Fig. 4).
Injection of lithium carbonate nano-scaled particles into the tumour growth region set conditions for increasing the macrophage
and neutrophil content in the regional structure of the tumour inguinal lymph node, as well as intensiﬁed destruction of tumour cells
and increased the development of vasculature.
After ﬁve-fold dosing of lithium nano-scaled particles into the tumour growth region, we noted stasis of erythrocytes in liver
sinusoids. In seven days after ﬁve-fold dosing of lithium nano-scaled particles into the tumour, local necrosis was observed in the
liver. Stasis of erythrocytes and abundance of monocytes and macrophages were also noted. Twenty-ﬁve days after ﬁve-fold dosing
of lithium nano-scaled particles into the tumour, numerous metastases of different sizes (from one to two cells up to several dozens
of polymorphous cells) were noticed in the liver. In addition to metastases, we also recordedmultiple macrophages in the parenchy-
ma; many monocytes, macrophages and neutrophils also ﬁlled gaps within sinusoids (Fig. 5).
Under the conditions of lithiumcarbonate nano-scaled particle introduction into the region of tumour growthwith developing he-
patocellular carcinoma (H-29), the number of macrophages grew in liver sinusoids and parenchyma. Within 30 days of the experi-
ment, regions with metastases in the liver were surrounded by a large number of macrophages. Lithium injection appears to
provoke considerable involvement of macrophages to the liver regions of tumour cell migration.
Correction of tumour process, which is developing in right thighmuscle after inoculation of hepatocellular carcinoma (H-29) cells,
with injections of lithium carbonate nano-scaled particle suspension directly into affected tissue introduced changes into dynamics of
lipid peroxidation processes' activity. Tumour growth in mice under conditions of correction with nano-scaled particles suppressed
processes of lipid peroxidation at an early stage and helped prevent spontaneous tumour development (Table 1).
However, during subsequent stages of the investigation, the level of TBA-active products in affected thigh tissue of treated mice
returned to the norm. At the same time, animals with spontaneous tumour development had signiﬁcant accumulation of lipid perox-
idation afterproducts. On day 7, animals that were treated with ﬁve-fold injection of lithium carbonate nano-scaled particles had 2.4
times less concentration of lipid peroxidation afterproducts comparedwith indexes, registered formicewith spontaneous tumour de-
velopment (Table 1). After 13 days, treated animals had the level of TBA-active productswithin frames of control values, and itwas 1.4
times lower than such index for mice with spontaneous hepatocellular carcinoma development. Thereby, the correction of tumour
process with lithium carbonate nano-scaled particles considerably inhibited the activity of lipid peroxidation processes in tissue
affected with hepatocellular carcinoma (H-29).Table 3
The concentration of TBA-active products in the lungs, heart, liver, kidneys and left thigh muscle of mice with hepatocellular carcinoma H-29 development under cor-
rection by lithium carbonate nano-scaled particles (М ± m).
Organs Terms of investigation
Intact (4) Day 3 (4) Day 7 (3) Day 13 (4) Day 33 (1)
Spontaneous development of hepatocellular carcinoma H-29 in the right thigh muscle
Thigh without tumour 10.86 ± 0.87 5.21 ± 0.76⁎ 3.81 ± 0.62⁎ 1.79
Lungs 8.1 ± 0.77 10.7 ± 1.73 16.42 ± 2.1⁎ 18.13 ± 3.54 22.04
Heart 10.46 ± 2.68 12.1 ± 1.27 16.25 ± 1.05⁎ 11.25 ± 4.13 15.38
Liver 27.21 ± 5.76 11.54 ± 3.05⁎ 16.03 ± 0.53⁎ 16.37 ± 5.47 19.36
Kidneys 25.98 ± 4.46 35.44 ± 7.01 18.64 ± 3.31 20.49 ± 5.53 8.01
Development of hepatocellular carcinoma H-29 in the right thigh muscle under correction by lithium carbonate nano-scaled particles
Thigh without tumour 3.99 ± 0.89⁎ 1.51
Lungs 22.95 ± 10.04 13.41 ± 2.0 28.54 ± 12.33 13.44
Heart 9.2 ± 2.22 16.31 ± 2.76 12.12 ± 5.42 21.23
Liver 19.33 ± 6.22 20.37 ± 7.04 27.1 ± 9.38 16.0
Kidneys 19.24 ± 3.49 17.15 ± 2.33 22.58 ± 7.69 12.22
Comment: the number of animals is stated in parentheses.
⁎ P b 0.05 compared with control.
Table 4
Catalase activity in the lungs, heart, liver, kidneys and left thighmuscle ofmicewith hepatocellular carcinomaH-29development under correction by lithium carbonate
nano-scaled particles (М ± m).
Organs Terms of investigation
Intact (4) Day 3 (4) Day 7 (3) Day 13 (4) Day 33 (1)
Spontaneous development of hepatocellular carcinoma H-29 in the right thigh muscle
Thigh without tumour 24.9 ± 7.7 94.1 ± 11.3⁎ 30.8
Lungs 260.8 ± 36.2 125.7 ± 9.2⁎ 124.8 ± 2.0⁎ 71.21 ± 26.97⁎ 164.8
Heart 52.0 ± 4.6 4.2 ± 0.8⁎ 21.7 ± 8.3⁎ 8.9 ± 3.9⁎ 76.5
Liver 110.7 ± 27.9 51.6 ± 17.4 137.0 ± 13.6 43.9 ± 12.4⁎ 75.2
Kidneys 168.8 ± 24.5 198.5 ± 26.7 21.3 ± 10.3⁎ 246.2 ± 55.3 221
Development of hepatocellular carcinoma H-29 in the right thigh muscle under correction by lithium carbonate nano-scaled particles
Thigh without tumour 94.08 ± 11.9+ 44.89
Lungs 135.2 ± 18.8⁎ 123.7 ± 4.8⁎⁎ 94.4 ± 11.9⁎ 85.1
Heart 14.4 ± 3.3⁎+ 15.1 ± 4.6⁎⁎ 15.0 ± 1.7⁎ 70.8
Liver 56.1 ± 19.0 183.9 ± 74.6 58.6 ± 12.0 84.6
Kidneys 202.6 ± 11.2 39.3 ± 21.1⁎ 209.6 ± 42.2 481.9
Comment: the number of animals is stated in parentheses.
⁎ P b 0.05.
⁎⁎ P b 0.01 compared with control.
+ P b 0.05 in comparison to animals with spontaneous tumour development.
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catalase activity, which is used to eliminate hydrogen peroxide from the tumour cells' microenvironment and to increase tumour
cells' active proliferation (Table 2).
The correction of tumour process with lithium nano-sized particles did not inﬂuence the level of catalase activity at all stages of
investigation. After seven days postinoculation of hepatocellular carcinoma (H-29) cells into the right thigh muscle, we observed a
decrease in superoxide dismutase activity, for treated and non-treated animals, which was successfully overcome in both groups of
mice by day 13 of tumour process development (Table 3).
It is known, that the content of superoxide dismutase in cells increases in response to increases in superoxide concentration
(Menshchikova et al., 2008). Lowered content of superoxide dismutase in tumour cells indicates the inhibition of superoxide's intra-
cellular production. It turned out that double-ply and ﬁve-fold introduction of lithium carbonate nano-scaled particles is not able to
sufﬁciently impact the transformation of intracellular metabolic processes associated with the formation and utilization of active ox-
ygen metabolites during tumour development.
During the study of distance effects of lithium carbonate nano-sized particles' multiple-dose introduction under tumour process devel-
opment, it was found that dynamic changes of activity of lipid peroxidation processes, registered by accumulation of TBA-active products
(malondialdehyde) in different parenchymatous organs— the lungs, heart, liver and kidney, were in frames of control values (Table 3).
Thus, correction of tumour process by introduction of lithium carbonate nano-scaled particles promoted the defence of vital
organs — the heart and lungs, from damaging effect of lipid peroxidation afterproducts. However, multiple-dose introduction of
nano-scaled particles did not inﬂuence the decreased level of lipid peroxidation in unaffected muscular tissue of the left thigh, with
tumour process development in the right thigh muscle. This is likely to do with the particularities of blood-vascular and functioning
of lymphatic vessels.Table 5
Superoxide dismutase activity in the lungs, heart, liver, kidneys and left thigh muscle of mice with hepatocellular carcinoma H-29 development under correction by
lithium carbonate nano-scaled particles (М ± m).
Organs Terms of investigation
Intact (4) Day 3 (4) Day 7 (3) Day 13 (4) Day 33 (1)
Spontaneous development of hepatocellular carcinoma H-29 in the right thigh muscle
Thigh without tumour 102.0 ± 37.5 70.5 ± 9.0 151.5
Lungs 788.8 ± 116.7 513.2 ± 58.1 547.2 ± 62.9 736.1 ± 144.8 267.9
Heart 117.7 ± 30.7 133.1 ± 21.6 75.6 ± 13.98 56.34 ± 5.41 12.0
Liver 92.07 ± 21.34 144.1 ± 70.1 77.88 ± 40.53 171.25 ± 39.5 119.5
Kidneys 142.4 ± 22.02 372.4 ± 40.6⁎ 356.5 ± 22.46⁎ 483.0 ± 81.4⁎ 393.8
Development of hepatocellular carcinoma H-29 in the right thigh muscle under correction by lithium carbonate nano-scaled particles
Thigh without tumour 60.3 ± 28.45 140.6
Lungs 654.1 ± 218.3 439.7 ± 98.37 674.1 ± 161.19 204.2
Heart 125.6 ± 21.92 57.21 ± 5.19 69.68 ± 7.8 228.0
Liver 72.12 ± 36.3 134.5 ± 61.8 187 ± 19.5 79.83
Kidneys 366.1 ± 16.74⁎ 367.7 ± 50.72⁎⁎ 409.2 ± 68.68⁎ 621.5
Comment: the number of animals is stated in parentheses.
⁎ P b 0.05.
⁎⁎ P b 0.01 compared with control.
Table 6
Changes of haemoglobin concentration in the thigh muscle of mice with hepatocellular carcinoma H-29 development under correction by lithium carbonate nano-
scaled particles (М ± m).
Organs Terms of investigation
Intact Day 3 (4) Day 7 Day 13 Day 3
Thigh without tumour 0.57 ± 0.09 (4) 0.19 (1)
Thigh with tumour 0.68 ± 0.09⁎ (4) 0.47 ± 0.04⁎⁎ (5) 0.67 ± 0.12⁎ (4) 0.22 (1)
Comment: the number of animals is stated in parentheses.
⁎ P b 0.05.
⁎⁎ P b 0.01 compared with control.
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release and formation of prime lipid radicals, which originate from rather low-activity superoxide anion-radical, hydrogen peroxide
(Menshchikova et al., 2008). Thereby, effects of nano-scaled particles' multiple-dose introduction on lipid peroxidation processes in
remote organs, while the tumour process developed in muscular tissue of the right thigh, could be mediated by changing of antiox-
idant enzymes' activity, which are able to eliminate initial agents in tissues. Thus, the decrease of catalase activity in cardiac muscle
under the development of hepatocellular carcinoma (H-29) andwith correction using lithiumcarbonate nano-sized particles,was sig-
niﬁcantly less expressed on the third day, whereas the rate of catalase activity in the hearts of treated animals exceeded the rate for
non-treated animals 3.4 times (Table 4).
We did not register any effects of the treatment on dynamic changes of catalase activity rate in the lungs, liver, kidney and unaf-
fected left thigh muscle under the development of tumour process (Table 4).
There was no noted inﬂuence of multiple-dose introduction of lithium nano-scaled particles on the dynamics of superoxide dis-
mutase activity in remote organs — the lungs, heart, liver, kidney and unaffected left thigh muscle (Table 5).
Thereby, introduction of lithium carbonate nano-scaled particles into the thighmuscle caused an increase in lipid peroxidation ac-
tivity in muscular tissue. This led to alteration within the tissue and the development of inﬂammatory inﬁltration, as indicated by an
increase in tissue protein concentration. After the development of an inﬂammatory response to the introduction of lithium carbonate
nano-scaled particles, there was a secondary increase in lipid peroxidation activity, leading to a secondary alteration. This secondary
alteration included an effect of the release of lysosomal enzymes and active oxygen metabolites from cells, in connective tissue and
microvessels. Introduction of lithium carbonate nano-scaled particles provoked the enhancement of catalase activity, which led to dy-
namic changes of lipid peroxidation intensity, and decrease of superoxide dismutase activity.
Evaluation of haemoglobin concentration revealed that on the third day of hepatocellular carcinoma development, the content of
haemoglobin in affectedmuscle of treatedmicewas two times higher comparedwith reference level. At the same time, the content of
haemoglobin for untreated mice did not change from the reference level (Table 6).
However, the tumour's systemic action on haemoglobin levels in unaffected muscle of the left thigh at the late stages (13th day)
disappeared under treatment. This is possibly indicative of nano-scaled particles indirect effects on decreasing the production of
VEGF-A, therefore affecting systemic circulation.
Multiple-dose introduction of lithium carbonate nano-scaled particles most likely contribute to the lower level of vascularisation
of hepatocellular carcinoma (H-29) fast-growing tumour node in muscular tissue. This conclusion is based on the lack of signiﬁcant
difference between the content of lactic acid for treated animals from the reference values on the 13th day, whereas non-treated an-
imals had a lactic acid index signiﬁcantly lower than reference values (Table 7).
Hereby, fast growth of vessels which supply the tumour, leads to a decrease of lactic acid accumulation in affectedmuscular tissue.
Two-fold introduction of lithium carbonate nano-scaled particles reliably increased the level of nitric oxide production by perito-
neal macrophages on day 3 of tumour process development in thigh muscular tissue (Fig. 6).
After introduction of lithium carbonate nano-scaled particles, our results show that the dynamics of lactic acid and triglycerides'
contentwas changing in the area of themuscular tissue inoculated by tumour cells. In cases of hepatocellular carcinoma development
without inﬂuence of lithium, lipid accumulation in muscular tissue occurs slowly, growing by the 13th day. In contrast, triglyceride
levels in treated mice on the third day after tumour process induction increased 4.7 times compared with the reference values,
which also exceeded rates in the animal group without impact by 1.7 times (Fig. 7). This ﬁnding correlates with previous research
showing that after addition of conjugate linoleic acid to hepatocellular carcinoma HepG2 culture, the inhibition of tumour cellTable 7
Change of lactate concentration in the thigh muscle of mice with spontaneous hepatocellular carcinoma H-29 development and under correction by lithium carbonate
nano-scaled particles (М ± m).
Animal groups Stages of investigation
Intact Day 3 (4) Day 13 Day 3
Spontaneous development 2.33 ± 0.05 (4) 3.50 ± 0.63 (4) 1.33 ± 0.11⁎ (4) 2.18 (1)
Under correction by lithium carbonate nano-scaled particles 4.91 ± 2.25 (4) 1.61 ± 0.37 (4) 2.79 (1)
Comment: the number of animals is stated in parentheses.
⁎ P b 0.05 compared with control.
Fig. 6.Dynamics of NO production by peritonealmacrophages,with hepatocellular carcinoma (H-29) development inmuscular tissue of right thigh under conditions of
correction using lithium carbonate nano-scaled particles. * — P b 0.05 compared with the group of intact animals.
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Fig. 7.Metabolic changes inmuscular tissue and liver under conditions of tumour growth and impact of lithium carbonate nano-scaled particles. ⁎ — P b 0.05 compared
with control.
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110 N.P. Bgatova et al. / Achievements in the Life Sciences 8 (2014) 101–111proliferation was accompanied by an increase in intracellular lipids (triglycerides, total cholesterol, free cholesterol) and fatty acid
concentration (Igarashi andMiyazawa, 2001). These results taken together show that changes inmetabolism of fatty acids inﬂuenced
on intensity of tumour cells' proliferation.
Lactic acid concentrations in the liver increased gradually in animals with spontaneous development of tumour process inmuscu-
lar tissue caused by the inoculation of hepatocellular carcinoma cells. On the 7th day of hepatocellular carcinoma development, the
concentration of lactate in the liver exceeded control values 3.9 times, and on the 13th day, it exceeded control values 6.2 times
(Fig. 7). This argued for activation of anaerobic glycolysis process and for development of anaemia hypoxic syndrome. Under condi-
tions lacking oxygen, mitochondrial breathing in cells reduces and ATP is produced by anaerobic glycolysis. Hypoxia-inducible factor,
a regulator of transcription for glucose metabolism enzymes (Pescador et al., 2010), plays the key role in this metabolic shift. In the
liver, lactate usually turns into glucose, and then through glycogenesis turns into glycogen. During our experiment, the level of
glycogen almost doubled— becoming 1.9 times higher comparedwith the reference level from day three of hepatocellular carcinoma
development (Fig. 7). The study showed that hypoxia can lead to accumulation of glycogen by enhancement of glucose ﬂux in the cell.
This occurs due to an increase in the level of a transporter protein, GLUT-1 and glucose's participation in its biosynthesis by activation
of glycogen synthase (Pescador et al., 2010). Thismechanism is conﬁrmed by cell culture studies, whichwere performed onmyocytes,
normal hepatocytes and cells of different hepatomas. Glycogen accumulation in cells improves their survivability under hypoxia.
During subsequent time-points in our study, the level of glycogen in liver tissue did not signiﬁcantly differ from the control group.
This study has shown that excess glucose enters into systemic circulation andwas consumedmore not by the tumour tissue, but by
other tissues because theirmetabolism switched to glucose's consumption due to lack of oxygen provision. In addition, excess glucose
was likely converted into triglycerides by the liver, as seen by the day three concentration of triglycerides being 3.1 times higher than
its rate in group of intact animals. Triglyceride accumulation in muscular tissue in the area inoculated by tumour cells can also be ex-
plained by signiﬁcant decreases in lipase, which decomposes neutral fats. Patients with liver cancer development experience damage
of liver cells, and activity of lipase, which hydrolyses triglycerides, goes down (Hiraoka et al., 1993). Correction of hepatocellular
carcinoma-29, developing in muscular tissue, by lithium carbonate nano-scaled particles did not inﬂuence the intensity of anaerobic
glycolysis or accumulation of glycogen and triglycerides in the liver because the dynamics of lactate, glycogen and triglycerides
concentration was the same as for animals with spontaneous tumour development (Fig. 7).
Conclusion
During the ﬁrst twoweeks of tumour process development inwhich lithium carbonate nano-scaled particles were introduced, we
monitored the activation of the drainage-detoxiﬁcation function of regional to tumour lymph node and metabolic processes in mus-
cular tissue and liver. Under conditions of tumour process progression, the protective barrier functions of the lymph nodes gradually
decreased. By the 30th day of the experiment, tumour cells disseminated into regional lymph nodes and the liver. Single andmultiple
doses of lithium carbonate nano-scaled particles on the periphery of tumour growth did not result in the removal of tumour cells from
the thighmuscular tissue. We also noted in the early stages after introduction that there was an increase of macrophages and neutro-
phils within the tumour, a decrease in bloodmicrovessel density and haemoglobin and an increase of tumour cell necrosis rate. Then,
in the late stages of tumour development there were destructive changes occurring in the cytoplasm and nuclei of tumour cells.
During tumour process development, neither single nor ﬁve-fold introduction of lithiumnano-scaled particles affected NOproduction
by peritoneal macrophages. Correction of tumour process by lithium carbonate nano-scaled particles inhibited activity of lipid perox-
idation processes in tissue which was affected by hepatocellular carcinoma by inoculation. However, it did not impact the activity of
antioxidant enzymes such as catalase and superoxide dismutase. The introduction of lithium carbonate nano-scaled particles into the
area of tumour growth protected vital organs such as the heart and lungs from the damaging effect of lipid peroxidation afterproducts.
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